Institute of Medical Microbiology, University Hospital Essen, University Duisburg-Essen, 45122 Essen, Germany.
J Exp Med. 2012 Oct 22;209(11):2001-16. doi: 10.1084/jem.20111497. Epub 2012 Oct 8.
Infiltration of Foxp3(+) regulatory T (T reg) cells is considered to be a critical step during tumor development and progression. T reg cells supposedly suppress locally an effective anti-tumor immune response within tumor tissues, although the precise mechanism by which T reg cells infiltrate the tumor is still unclear. We provide evidence that Neuropilin 1 (Nrp-1), highly expressed by Foxp3(+) T reg cells, regulates the immunological anti-tumor control by guiding T reg cells into the tumor in response to tumor-derived vascular endothelial growth factor (VEGF). We demonstrate for the first time that T cell-specific ablation of Nrp-1 expression results in a significant breakdown in tumor immune escape in various transplantation models and in a spontaneous, endogenously driven melanoma model associated with strongly reduced tumor growth and prolonged tumor-free survival. Strikingly, numbers of tumor-infiltrating Foxp3(+) T reg cells were significantly reduced accompanied by enhanced activation of CD8(+) T cells within tumors of T cell-specific Nrp-1-deficient mice. This phenotype can be reversed by adoptive transfer of Nrp-1(+) T reg cells from wild-type mice. Thus, our data strongly suggest that Nrp-1 acts as a key mediator of Foxp3(+) T reg cell infiltration into the tumor site resulting in a dampened anti-tumor immune response and enhanced tumor progression.
Foxp3(+) 调节性 T(Treg)细胞的浸润被认为是肿瘤发展和进展过程中的一个关键步骤。Treg 细胞据称会在肿瘤组织内抑制局部有效的抗肿瘤免疫反应,尽管 Treg 细胞浸润肿瘤的确切机制仍不清楚。我们提供的证据表明,高表达于 Foxp3(+) Treg 细胞的神经纤毛蛋白 1(Nrp-1)通过引导 Treg 细胞进入肿瘤来调节免疫性抗肿瘤控制,以响应肿瘤衍生的血管内皮生长因子(VEGF)。我们首次证明,T 细胞特异性 Nrp-1 表达的缺失会导致各种移植模型中的肿瘤免疫逃逸显著破坏,以及与肿瘤生长明显减少和无肿瘤存活时间延长相关的自发、内源性驱动的黑色素瘤模型。引人注目的是,肿瘤内浸润的 Foxp3(+) Treg 细胞数量显著减少,同时 T 细胞特异性 Nrp-1 缺陷小鼠肿瘤内的 CD8(+) T 细胞激活增强。这种表型可以通过从野生型小鼠中过继转移 Nrp-1(+) Treg 细胞来逆转。因此,我们的数据强烈表明,Nrp-1 作为 Foxp3(+) Treg 细胞浸润肿瘤部位的关键介质,导致抗肿瘤免疫反应减弱和肿瘤进展增强。